ATR
Price
$122.70
Change
+$0.65 (+0.53%)
Updated
Dec 4, 11:39 AM (EDT)
Capitalization
8.01B
70 days until earnings call
Intraday BUY SELL Signals
IQV
Price
$222.46
Change
-$4.78 (-2.10%)
Updated
Dec 4, 01:49 PM (EDT)
Capitalization
38.7B
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATR vs IQV

Header iconATR vs IQV Comparison
Open Charts ATR vs IQVBanner chart's image
AptarGroup
Price$122.70
Change+$0.65 (+0.53%)
Volume$206
Capitalization8.01B
IQVIA Holdings
Price$222.46
Change-$4.78 (-2.10%)
Volume$100
Capitalization38.7B
ATR vs IQV Comparison Chart in %
ATR
Daily Signal:
Gain/Loss:
IQV
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ATR vs. IQV commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATR is a Hold and IQV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ATR: $122.06 vs. IQV: $227.24)
Brand notoriety: ATR: Not notable vs. IQV: Notable
ATR represents the Pharmaceuticals: Other, while IQV is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATR: 94% vs. IQV: 77%
Market capitalization -- ATR: $8.01B vs. IQV: $38.7B
ATR [@Pharmaceuticals: Other] is valued at $8.01B. IQV’s [@Medical Specialties] market capitalization is $38.7B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $201.96B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.95B. The average market capitalization across the [@Medical Specialties] industry is $12.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATR’s FA Score shows that 0 FA rating(s) are green whileIQV’s FA Score has 2 green FA rating(s).

  • ATR’s FA Score: 0 green, 5 red.
  • IQV’s FA Score: 2 green, 3 red.
According to our system of comparison, IQV is a better buy in the long-term than ATR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATR’s TA Score shows that 4 TA indicator(s) are bullish while IQV’s TA Score has 4 bullish TA indicator(s).

  • ATR’s TA Score: 4 bullish, 4 bearish.
  • IQV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IQV is a better buy in the short-term than ATR.

Price Growth

ATR (@Pharmaceuticals: Other) experienced а -1.41% price change this week, while IQV (@Medical Specialties) price change was -1.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.39%. For the same industry, the average monthly price growth was +7.92%, and the average quarterly price growth was +3.54%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.64%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was +27.59%.

Reported Earning Dates

ATR is expected to report earnings on Feb 12, 2026.

IQV is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (-0.64% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IQV($38.7B) has a higher market cap than ATR($8.01B). IQV has higher P/E ratio than ATR: IQV (31.26) vs ATR (19.59). IQV YTD gains are higher at: 15.638 vs. ATR (-21.584). IQV has higher annual earnings (EBITDA): 3.35B vs. ATR (841M). ATR has less debt than IQV: ATR (1.25B) vs IQV (15.7B). IQV has higher revenues than ATR: IQV (15.7B) vs ATR (3.66B).
ATRIQVATR / IQV
Capitalization8.01B38.7B21%
EBITDA841M3.35B25%
Gain YTD-21.58415.638-138%
P/E Ratio19.5931.2663%
Revenue3.66B15.7B23%
Total CashN/A2.19B-
Total Debt1.25B15.7B8%
FUNDAMENTALS RATINGS
ATR vs IQV: Fundamental Ratings
ATR
IQV
OUTLOOK RATING
1..100
5069
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
8173
SMR RATING
1..100
5345
PRICE GROWTH RATING
1..100
6311
P/E GROWTH RATING
1..100
8924
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATR's Valuation (60) in the Containers Or Packaging industry is in the same range as IQV (73) in the Servicestothe Health Industry industry. This means that ATR’s stock grew similarly to IQV’s over the last 12 months.

IQV's Profit vs Risk Rating (73) in the Servicestothe Health Industry industry is in the same range as ATR (81) in the Containers Or Packaging industry. This means that IQV’s stock grew similarly to ATR’s over the last 12 months.

IQV's SMR Rating (45) in the Servicestothe Health Industry industry is in the same range as ATR (53) in the Containers Or Packaging industry. This means that IQV’s stock grew similarly to ATR’s over the last 12 months.

IQV's Price Growth Rating (11) in the Servicestothe Health Industry industry is somewhat better than the same rating for ATR (63) in the Containers Or Packaging industry. This means that IQV’s stock grew somewhat faster than ATR’s over the last 12 months.

IQV's P/E Growth Rating (24) in the Servicestothe Health Industry industry is somewhat better than the same rating for ATR (89) in the Containers Or Packaging industry. This means that IQV’s stock grew somewhat faster than ATR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRIQV
RSI
ODDS (%)
Bullish Trend 7 days ago
43%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
51%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bullish Trend 7 days ago
43%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 7 days ago
55%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
53%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
54%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 7 days ago
54%
Bullish Trend 10 days ago
60%
Declines
ODDS (%)
Bearish Trend 16 days ago
51%
Bearish Trend 7 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
46%
Bearish Trend 2 days ago
47%
Aroon
ODDS (%)
Bearish Trend 7 days ago
72%
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
ATR
Daily Signal:
Gain/Loss:
IQV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGFCX75.39N/A
N/A
American Funds Growth Fund of Amer 529C
AZNIX12.38N/A
N/A
Virtus Income & Growth Inst
TBWIX22.46N/A
N/A
Thornburg Better World International I
BDHKX8.96N/A
N/A
BlackRock Dynamic High Income K
BTEUX15.59N/A
N/A
Baron Technology R6

ATR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATR has been loosely correlated with SYK. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATR jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATR
1D Price
Change %
ATR100%
-1.30%
SYK - ATR
52%
Loosely correlated
-1.51%
AVTR - ATR
51%
Loosely correlated
-0.85%
A - ATR
51%
Loosely correlated
-0.85%
IQV - ATR
50%
Loosely correlated
-1.23%
RVTY - ATR
49%
Loosely correlated
+0.33%
More

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with TMO. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
+0.71%
TMO - IQV
76%
Closely correlated
+0.01%
A - IQV
76%
Closely correlated
+0.30%
MTD - IQV
76%
Closely correlated
-0.85%
RVTY - IQV
75%
Closely correlated
+0.52%
CRL - IQV
73%
Closely correlated
+5.67%
More